Baird Financial Group, Inc. - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 39 filers reported holding SAB BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,300
-24.1%
10,0000.0%0.00%
Q2 2023$8,300
+88.6%
10,0000.0%0.00%
Q1 2023$4,400
+73233.3%
10,0000.0%0.00%
Q4 2022$610,0000.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$4760.14%
Warberg Asset Management LLC 370,370$218,5180.03%
METEORA CAPITAL, LLC 134,524$79,3560.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 149,774$88,3520.02%
SILVER OAK SECURITIES, Inc 51,941$310.01%
Veritable, L.P. 506,513$298,7920.01%
Shaolin Capital Management LLC 236,621$1400.00%
Elgethun Capital Management 14,796$9,1710.00%
LGL PARTNERS, LLC 23,000$13,5680.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$49,5520.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders